RASBURICASE

RASBURICASE was reported 2475 times

RASBURICASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 SEPSIS 13 0.3611
1 CUTANEOUS T-CELL LYMPHOMA STAGE I 9 0.2500
2 HAEMOPHILUS BACTERAEMIA 6 0.1224
3 SEPTUM PELLUCIDUM AGENESIS 6 0.1000
4 CT HYPOTENSION COMPLEX 1 0.1000
5 GASTROINTESTINAL DILATION PROCEDURE 3 0.0638
6 TRANSIENT APHASIA 8 0.0611
7 ANISOCHROMIA 1 0.0556
8 LYMPHOID TISSUE HYPOPLASIA 8 0.0523
9 THYMUS HYPOPLASIA 8 0.0460
10 ACQUIRED METHAEMOGLOBINAEMIA 2 0.0455
11 CEREBRAL MICROEMBOLISM 1 0.0455
12 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA 2 0.0435
13 MYOCARDIAL CALCIFICATION 5 0.0427
14 TUMOUR LYSIS SYNDROME 364 0.0413
15 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
16 PSEUDOHYPONATRAEMIA 5 0.0365
17 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV 1 0.0357
18 STOMA SITE CELLULITIS 2 0.0351
19 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 8 0.0343
20 METHAEMOGLOBINAEMIA 74 0.0319
21 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 8 0.0273
22 SUBDURAL HYGROMA 8 0.0263
23 MYELOBLAST COUNT INCREASED 2 0.0260
24 URATE NEPHROPATHY 3 0.0259
25 RENAL ISCHAEMIA 14 0.0256
26 CONJUNCTIVAL PIGMENTATION 1 0.0250
27 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 6 0.0248
28 EAR INFECTION STAPHYLOCOCCAL 3 0.0246
29 CENTRAL-ALVEOLAR HYPOVENTILATION 1 0.0222
30 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 4 0.0205
31 HYPOFIBRINOGENAEMIA 20 0.0202
32 ALLERGIC TRANSFUSION REACTION 3 0.0199
33 CELL-MEDIATED CYTOTOXICITY 1 0.0196
34 CONGENITAL HIATUS HERNIA 4 0.0175
35 DEVICE RELATED BACTERAEMIA 5 0.0161
36 LARYNGEAL INFLAMMATION 3 0.0160
37 ANTI-HBS ANTIBODY POSITIVE 1 0.0156
38 ANTACID THERAPY 2 0.0154
39 CAPILLARY PERMEABILITY INCREASED 1 0.0154
40 SKIN LESION INFLAMMATION 2 0.0152
41 NASAL FLARING 2 0.0149
42 DISSEMINATED ASPERGILLOSIS 7 0.0148
43 HYPERPHOSPHATAEMIA 31 0.0144
44 BLOOD URIC ACID DECREASED 7 0.0144
45 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
46 MYELOMA CAST NEPHROPATHY 2 0.0141
47 ADENOVIRUS REACTIVATION 2 0.0139
48 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 2 0.0132
49 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 9 0.0129
50 MYOCARDIAL NECROSIS 3 0.0129
51 BLOOD PHOSPHORUS INCREASED 34 0.0124
52 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 1 0.0123
53 BLOOD URIC ACID ABNORMAL 5 0.0123
54 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 4 0.0122
55 BLADDER OUTLET OBSTRUCTION 2 0.0121
56 BLASTOCYSTIS INFECTION 1 0.0115
57 HAEMOPERITONEUM 9 0.0112
58 CARDIAC SEPTAL DEFECT 8 0.0111
59 NECROTISING COLITIS 14 0.0110
60 ACINETOBACTER BACTERAEMIA 2 0.0106
61 ENTEROCOCCAL BACTERAEMIA 11 0.0104
62 APPENDICOLITH 4 0.0103
63 SLEEP DISORDER THERAPY 2 0.0101
64 BACILLUS TEST POSITIVE 1 0.0101
65 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
66 ASPERGILLUS TEST POSITIVE 3 0.0097
67 MALIGNANT MELANOMA STAGE 0 2 0.0096
68 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
69 ANALGESIC THERAPY 3 0.0093
70 CARDIOVASCULAR INSUFFICIENCY 15 0.0092
71 PSEUDOMONAL SEPSIS 16 0.0091
72 BLOOD METHAEMOGLOBIN PRESENT 1 0.0090
73 ACID BASE BALANCE ABNORMAL 2 0.0089
74 COAGULATION FACTOR VII LEVEL DECREASED 1 0.0088
75 DRUG THERAPY 3 0.0088
76 TUMOUR FLARE 6 0.0088
77 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
78 CRUSH INJURY 1 0.0078
79 BACTEROIDES INFECTION 2 0.0077
80 CYTOTOXIC OEDEMA 2 0.0075
81 LABILE HYPERTENSION 2 0.0072
82 PARAINFLUENZAE VIRUS INFECTION 11 0.0072
83 ANTICOAGULANT THERAPY 2 0.0070
84 ABSCESS STERILE 1 0.0068
85 CAECITIS 3 0.0067
86 CYTOKINE RELEASE SYNDROME 133 0.0066
87 QUADRIPARESIS 11 0.0066
88 ERYTHROPOIESIS ABNORMAL 2 0.0065
89 ACUTE PHOSPHATE NEPHROPATHY 1 0.0064
90 VASCULAR COMPRESSION 2 0.0063
91 ENTEROCOCCAL SEPSIS 5 0.0062
92 ACTION TREMOR 1 0.0062
93 ADNEXA UTERI CYST 1 0.0061
94 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 36 0.0061
95 GASTROENTERITIS BACTERIAL 2 0.0060
96 BLOOD LACTATE DEHYDROGENASE DECREASED 2 0.0060
97 CORONAVIRUS PNEUMONIA 1 0.0060
98 BLOOD URIC ACID INCREASED 34 0.0059
99 ENTEROVIRUS INFECTION 5 0.0058
100 SECONDARY IMMUNODEFICIENCY 7 0.0058
101 BASE EXCESS DECREASED 1 0.0056
102 DIFFERENTIATION SYNDROME 4 0.0054
103 ENTEROCOLITIS INFECTIOUS 5 0.0054
104 CEREBRAL HAEMATOMA 18 0.0054
105 BLOOD FIBRINOGEN DECREASED 6 0.0053
106 ADMINISTRATION SITE REACTION 2 0.0052
107 FEBRILE BONE MARROW APLASIA 22 0.0052
108 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
109 BIOPSY KIDNEY ABNORMAL 1 0.0051
110 DEVICE RELATED THROMBOSIS 5 0.0051
111 CHEST WALL ABSCESS 1 0.0051
112 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
113 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 1 0.0048
114 CHLOROMA 2 0.0047
115 HAEMOLYTIC ANAEMIA 41 0.0046
116 CARDIOMYOPATHY ACUTE 1 0.0046
117 ABDOMINAL MASS 12 0.0045
118 REFUSAL OF TREATMENT BY RELATIVE 2 0.0044
119 HYPERURICAEMIA 18 0.0044
120 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
121 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
122 ANGIOSARCOMA 2 0.0043
123 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 4 0.0043
124 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
125 SYSTEMIC MYCOSIS 5 0.0043
126 BONE MARROW NECROSIS 1 0.0043
127 ESCHERICHIA BACTERAEMIA 10 0.0042
128 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
129 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
130 KLEBSIELLA BACTERAEMIA 4 0.0042
131 NEUTROPENIC INFECTION 4 0.0042
132 BACTERIAL DISEASE CARRIER 3 0.0041
133 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
134 HYPERTRIGLYCERIDAEMIA 23 0.0039
135 NEUTROPENIC SEPSIS 28 0.0039
136 HAEMOLYSIS 30 0.0039
137 B-CELL APLASIA 1 0.0039
138 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 10 0.0039
139 NEUTROPENIC COLITIS 8 0.0039
140 PRODUCT INEFFECTIVE 3 0.0038
141 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
142 GUILLAIN-BARRE SYNDROME 18 0.0037
143 MULTIPLE ORGAN DYSFUNCTION SYNDROME 103 0.0036
144 PSEUDOMONAS INFECTION 31 0.0036
145 GASTRIC DILATATION 6 0.0036
146 RHINOVIRUS INFECTION 14 0.0036
147 INTRAVASCULAR HAEMOLYSIS 2 0.0036
148 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
149 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 26 0.0035
150 VASOCONSTRICTION 3 0.0034
151 CATHETER SITE CELLULITIS 1 0.0034
152 FOLLICULAR LYMPHOMA 3 0.0034
153 ENGRAFTMENT SYNDROME 2 0.0034
154 CAPILLARY LEAK SYNDROME 7 0.0034
155 AORTIC VALVE STENOSIS 6 0.0034
156 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
157 PLASMA CELL LEUKAEMIA 2 0.0033
158 SUPERIOR VENA CAVA SYNDROME 2 0.0033
159 FEBRILE NEUTROPENIA 217 0.0033
160 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
161 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
162 SYSTEMIC CANDIDA 8 0.0032
163 HYPERCHLORAEMIA 2 0.0031
164 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
165 ILEAL PERFORATION 2 0.0030
166 HYPERBILIRUBINAEMIA 31 0.0030
167 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
168 BLOOD LACTATE DEHYDROGENASE ABNORMAL 2 0.0029
169 BRAIN STEM INFARCTION 3 0.0029
170 MUCOUS MEMBRANE DISORDER 4 0.0029
171 GALLBLADDER ENLARGEMENT 3 0.0028
172 CARDIAC ENZYMES INCREASED 2 0.0028
173 ABSCESS BACTERIAL 1 0.0028
174 OVARIAN MASS 2 0.0027
175 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
176 HAEMOGLOBINURIA 3 0.0027
177 SERONEGATIVE ARTHRITIS 3 0.0026
178 COAGULATION TEST ABNORMAL 2 0.0026
179 OSTEOCHONDROSIS 3 0.0026
180 APLASIA 5 0.0026
181 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
182 STREPTOCOCCAL SEPSIS 3 0.0025
183 CHRONIC LYMPHOCYTIC LEUKAEMIA 12 0.0025
184 HAPTOGLOBIN DECREASED 2 0.0025
185 SUDDEN HEARING LOSS 5 0.0025
186 LINEAR IGA DISEASE 4 0.0024
187 URINARY TRACT INFECTION BACTERIAL 6 0.0024
188 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
189 PROCEDURAL HYPOTENSION 2 0.0024
190 CORONA VIRUS INFECTION 1 0.0023
191 PULMONARY CAVITATION 2 0.0023
192 HYPERLEUKOCYTOSIS 2 0.0023
193 INTESTINAL DILATATION 3 0.0022
194 BIOPSY BONE MARROW ABNORMAL 1 0.0022
195 URINE ABNORMALITY 10 0.0022
196 NEUROLOGICAL DECOMPENSATION 5 0.0022
197 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
198 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
199 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 2 0.0021
200 CELL MARKER INCREASED 1 0.0021
201 CARDIAC VALVE VEGETATION 1 0.0021
202 HAEMATOLOGICAL INFECTION 5 0.0020
203 DUODENAL PERFORATION 2 0.0020
204 CYTOMEGALOVIRUS VIRAEMIA 9 0.0020
205 MANTLE CELL LYMPHOMA 3 0.0020
206 FUNGAEMIA 3 0.0019
207 HYPOPERFUSION 2 0.0019
208 URINE KETONE BODY PRESENT 3 0.0019
209 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
210 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
211 HYPERCALCAEMIA 23 0.0019
212 ENTEROCOCCAL INFECTION 9 0.0019
213 ACUTE LEUKAEMIA 3 0.0019
214 BLOOD GASES ABNORMAL 1 0.0019
215 STREPTOCOCCAL BACTERAEMIA 2 0.0018
216 HAEMODYNAMIC INSTABILITY 14 0.0018
217 NOSOCOMIAL INFECTION 4 0.0018
218 BLOOD MAGNESIUM ABNORMAL 1 0.0018
219 BRAIN SCAN ABNORMAL 1 0.0018
220 CATHETER SITE INFLAMMATION 1 0.0018
221 DISTRIBUTIVE SHOCK 4 0.0018
222 OXYGEN SATURATION ABNORMAL 5 0.0018
223 HYPERKALAEMIA 61 0.0017
224 CELLULITIS ORBITAL 1 0.0017
225 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
226 VENTRICULAR FIBRILLATION 19 0.0017
227 FEBRILE INFECTION 2 0.0017
228 HEPATOCELLULAR INJURY 24 0.0017
229 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
230 CEREBRAL ASPERGILLOSIS 1 0.0016
231 BLOOD BILIRUBIN DECREASED 1 0.0016
232 MALIGNANT MELANOMA IN SITU 2 0.0016
233 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
234 BILIARY TRACT INFECTION 1 0.0016
235 VENOOCCLUSIVE DISEASE 4 0.0016
236 BLOOD BICARBONATE DECREASED 3 0.0016
237 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
238 ENDOCRINE DISORDER 2 0.0016
239 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
240 METABOLIC DISORDER 9 0.0015
241 BACTERIAL SEPSIS 5 0.0015
242 C-REACTIVE PROTEIN DECREASED 1 0.0015
243 ANISOCYTOSIS 1 0.0015
244 BLOOD LACTIC ACID INCREASED 8 0.0015
245 POLYDIPSIA 6 0.0015
246 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
247 HYPOXIA 53 0.0015
248 BRONCHITIS VIRAL 1 0.0015
249 LYMPHOPENIA 21 0.0015
250 ABSCESS NECK 1 0.0015
251 OLIGURIA 9 0.0014
252 RASH VESICULAR 7 0.0014
253 SERUM SICKNESS 4 0.0014
254 PROTHROMBIN TIME SHORTENED 2 0.0014
255 NEUROTOXICITY 25 0.0014
256 SEPTIC SHOCK 62 0.0014
257 CULTURE URINE POSITIVE 2 0.0014
258 RENAL TUBULAR DISORDER 4 0.0014
259 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
260 BLOOD POTASSIUM INCREASED 23 0.0014
261 SKIN WEEPING 5 0.0014
262 ANTIBODY TEST ABNORMAL 1 0.0014
263 ESCHERICHIA SEPSIS 4 0.0014
264 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
265 GASTROINTESTINAL NECROSIS 4 0.0014
266 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
267 NORMOCYTIC ANAEMIA 2 0.0014
268 ACUTE MYELOID LEUKAEMIA 21 0.0013
269 MUCOSAL INFLAMMATION 35 0.0013
270 METABOLIC ENCEPHALOPATHY 4 0.0013
271 SERUM FERRITIN INCREASED 7 0.0013
272 RESPIRATORY FAILURE 95 0.0013
273 ASPIRATION PLEURAL CAVITY 1 0.0013
274 TOXIC SKIN ERUPTION 13 0.0013
275 ONYCHOLYSIS 2 0.0013
276 RESPIRATORY ACIDOSIS 5 0.0013
277 BLOOD FIBRINOGEN INCREASED 1 0.0013
278 PNEUMONIA FUNGAL 5 0.0013
279 TOTAL LUNG CAPACITY DECREASED 2 0.0013
280 AZOTAEMIA 5 0.0013
281 IMMUNOSUPPRESSION 11 0.0012
282 CYTOPENIA 15 0.0012
283 HYPOGAMMAGLOBULINAEMIA 8 0.0012
284 HYPOPHOSPHATAEMIA 9 0.0012
285 ENCEPHALOPATHY 29 0.0012
286 BACTERAEMIA 14 0.0012
287 B-CELL LYMPHOMA 4 0.0012
288 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
289 ENTERITIS INFECTIOUS 2 0.0012
290 CANCER PAIN 3 0.0012
291 ANURIA 10 0.0012
292 HAEMATOTOXICITY 11 0.0012
293 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
294 HYPERSENSITIVITY VASCULITIS 3 0.0011
295 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
296 BLOOD POTASSIUM ABNORMAL 3 0.0011
297 CANDIDA SEPSIS 1 0.0011
298 VOCAL CORD PARALYSIS 2 0.0011
299 BRUXISM 6 0.0011
300 SUSPECTED OFF LABEL USE 5 0.0011
301 SOFT TISSUE INFECTION 2 0.0011
302 PANCYTOPENIA 61 0.0011
303 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
304 PNEUMONIA KLEBSIELLA 2 0.0011
305 PLEURITIC PAIN 3 0.0011
306 PNEUMOPERITONEUM 2 0.0011
307 PLASMACYTOMA 2 0.0011
308 LUNG CONSOLIDATION 3 0.0011
309 PRODUCT PREPARATION ISSUE 7 0.0011
310 SMALL INTESTINAL PERFORATION 2 0.0011
311 ASPERGILLUS INFECTION 7 0.0011
312 BLOOD UREA ABNORMAL 1 0.0011
313 INFECTED SKIN ULCER 2 0.0011
314 FACIAL PARALYSIS 9 0.0011
315 COR PULMONALE 1 0.0010
316 ACIDOSIS 8 0.0010
317 CARDIOGENIC SHOCK 15 0.0010
318 MULTI-ORGAN FAILURE 18 0.0010
319 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
320 HYPOALBUMINAEMIA 8 0.0010
321 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
322 ORAL INFECTION 4 0.0010
323 LUNG INFILTRATION 9 0.0010
324 OCCULT BLOOD POSITIVE 2 0.0010
325 HYPERVOLAEMIA 5 0.0010
326 GENE MUTATION 2 0.0010
327 CELL DEATH 2 0.0010
328 NEUTROPENIA 137 0.0010
329 CANDIDA INFECTION 17 0.0010
330 HYPERNATRAEMIA 5 0.0010
331 MIXED LIVER INJURY 3 0.0010
332 DEVICE RELATED SEPSIS 2 0.0010
333 MUCOSAL DRYNESS 2 0.0010
334 BONE MARROW FAILURE 20 0.0010
335 DIVERTICULAR PERFORATION 2 0.0010
336 ACUTE KIDNEY INJURY 148 0.0010
337 ABSCESS JAW 1 0.0010
338 PERIORBITAL OEDEMA 5 0.0010
339 BLAST CELL COUNT INCREASED 1 0.0010
340 NON-CARDIAC CHEST PAIN 3 0.0009
341 ELECTROLYTE IMBALANCE 11 0.0009
342 BLOOD SODIUM ABNORMAL 1 0.0009
343 CEREBRAL ARTERY OCCLUSION 1 0.0009
344 SEPSIS 104 0.0009
345 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
346 EXOPHTHALMOS 2 0.0009
347 LYMPHOCYTOSIS 2 0.0009
348 FACIAL PALSY 2 0.0009
349 PERIODONTITIS 2 0.0009
350 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
351 LYMPHOCYTE COUNT INCREASED 3 0.0009
352 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
353 SINUS TACHYCARDIA 13 0.0009
354 ACINETOBACTER INFECTION 1 0.0009
355 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
356 HEART RATE ABNORMAL 5 0.0009
357 IRON DEFICIENCY 4 0.0009
358 GRANULOCYTOPENIA 5 0.0009
359 LEFT VENTRICULAR FAILURE 3 0.0009
360 RESPIRATORY DISTRESS 24 0.0009
361 CEREBRAL VENTRICLE DILATATION 1 0.0009
362 ACUTE PRERENAL FAILURE 1 0.0009
363 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
364 AORTIC STENOSIS 3 0.0009
365 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
366 BILIRUBIN CONJUGATED INCREASED 2 0.0009
367 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
368 ABNORMAL FAECES 7 0.0009
369 COVID-19 PNEUMONIA 10 0.0008
370 HYPOCALCAEMIA 16 0.0008
371 METABOLIC ACIDOSIS 27 0.0008
372 INTERCEPTED PRODUCT STORAGE ERROR 3 0.0008
373 SUBDURAL HAEMATOMA 12 0.0008
374 BONE LESION 3 0.0008
375 HEPATITIS CHOLESTATIC 5 0.0008
376 HEPATITIS B 5 0.0008
377 HEPATIC FAILURE 25 0.0008
378 ORAL INTAKE REDUCED 2 0.0008
379 CLOSTRIDIUM COLITIS 1 0.0008
380 PRODUCT PACKAGING CONFUSION 2 0.0008
381 BLOOD CREATININE INCREASED 53 0.0008
382 HEPATOTOXICITY 18 0.0008
383 NERVOUS SYSTEM DISORDER 25 0.0008
384 CATHETER SITE HAEMORRHAGE 2 0.0008
385 CHRONIC SINUSITIS 3 0.0008
386 METASTASES TO PERITONEUM 2 0.0008
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
388 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
389 NEUTROPHIL COUNT DECREASED 32 0.0008
390 BLOOD TEST ABNORMAL 11 0.0008
391 HEPATOSPLENOMEGALY 2 0.0008
392 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
393 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
394 BILIARY OBSTRUCTION 1 0.0008
395 VENTRICULAR DYSFUNCTION 2 0.0008
396 CARDIOPULMONARY FAILURE 3 0.0008
397 LUNG OPACITY 2 0.0008
398 BACTERIAL INFECTION 14 0.0007
399 ANION GAP INCREASED 1 0.0007
400 ORGAN FAILURE 3 0.0007
401 TACHYPNOEA 10 0.0007
402 CHOLESTASIS 14 0.0007
403 ACUTE RESPIRATORY FAILURE 14 0.0007
404 ATELECTASIS 7 0.0007
405 COAGULOPATHY 12 0.0007
406 LEUKOPENIA 36 0.0007
407 THROMBOCYTOPENIA 80 0.0007
408 HAEMODIALYSIS 6 0.0007
409 ACUTE PULMONARY OEDEMA 4 0.0007
410 BLOOD CALCIUM DECREASED 8 0.0007
411 BUNDLE BRANCH BLOCK LEFT 3 0.0007
412 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
413 NECK MASS 2 0.0007
414 RESPIRATORY SYMPTOM 2 0.0007
415 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
416 OCULAR ICTERUS 3 0.0007
417 HAEMOTHORAX 2 0.0007
418 SPLENOMEGALY 8 0.0007
419 PRODUCT PREPARATION ERROR 14 0.0007
420 CARDIAC FIBRILLATION 1 0.0007
421 APRAXIA 1 0.0007
422 ATYPICAL PNEUMONIA 2 0.0007
423 CHROMATURIA 15 0.0007
424 MYELOFIBROSIS 2 0.0007
425 VASCULAR DEVICE INFECTION 3 0.0007
426 PROSTATITIS 2 0.0007
427 TROPONIN INCREASED 5 0.0007
428 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
429 HYPERTHERMIA 5 0.0007
430 LUMBAR VERTEBRAL FRACTURE 3 0.0007
431 INFUSION RELATED REACTION 43 0.0006
432 DIASTOLIC DYSFUNCTION 2 0.0006
433 APPENDICITIS 6 0.0006
434 PULMONARY HAEMORRHAGE 5 0.0006
435 ASPIRATION 7 0.0006
436 BLOOD BILIRUBIN INCREASED 17 0.0006
437 HYPOKALAEMIA 29 0.0006
438 PNEUMONIA VIRAL 2 0.0006
439 VENTRICULAR HYPOKINESIA 2 0.0006
440 MYASTHENIA GRAVIS 5 0.0006
441 HEPATITIS ACUTE 4 0.0006
442 RENAL TUBULAR NECROSIS 6 0.0006
443 RENAL FAILURE 81 0.0006
444 DEAFNESS NEUROSENSORY 2 0.0006
445 CYTOLYTIC HEPATITIS 2 0.0006
446 PRODUCT PRESCRIBING ISSUE 13 0.0006
447 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
448 PERICARDITIS 10 0.0006
449 KLEBSIELLA INFECTION 3 0.0006
450 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
451 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
452 BLOOD PH DECREASED 1 0.0006
453 TRANSAMINASES INCREASED 13 0.0006
454 BLOOD AMYLASE INCREASED 1 0.0006
455 DRUG RESISTANCE 15 0.0006
456 C-REACTIVE PROTEIN INCREASED 21 0.0006
457 STAPHYLOCOCCAL INFECTION 19 0.0006
458 PLEURAL EFFUSION 35 0.0006
459 HYPERTRANSAMINASAEMIA 4 0.0006
460 PETECHIAE 6 0.0006
461 HYPOMAGNESAEMIA 8 0.0006
462 CARDIO-RESPIRATORY ARREST 24 0.0006
463 THROMBOPHLEBITIS 2 0.0006
464 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
465 LYMPHOCYTE COUNT DECREASED 10 0.0006
466 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
467 RESPIRATORY RATE INCREASED 5 0.0006
468 APHASIA 17 0.0006
469 ANAL FISSURE 3 0.0006
470 FLUID OVERLOAD 8 0.0005
471 BLOOD PHOSPHORUS DECREASED 2 0.0005
472 RENAL FAILURE ACUTE 23 0.0005
473 SKIN DISORDER 18 0.0005
474 BLOOD UREA INCREASED 9 0.0005
475 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
476 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
477 HYPONATRAEMIA 30 0.0005
478 ORAL CANDIDIASIS 7 0.0005
479 SKIN TOXICITY 3 0.0005
480 CIRCULATORY COLLAPSE 9 0.0005
481 BONE MARROW TRANSPLANT 1 0.0005
482 BILE DUCT OBSTRUCTION 1 0.0005
483 ALANINE AMINOTRANSFERASE INCREASED 32 0.0005
484 SINUS BRADYCARDIA 5 0.0005
485 RALES 3 0.0005
486 REHABILITATION THERAPY 2 0.0005
487 PRODUCT LABEL CONFUSION 3 0.0005
488 SPINAL CORD COMPRESSION 2 0.0005
489 PLASMA CELL MYELOMA 20 0.0005
490 ABDOMINAL WALL HAEMATOMA 1 0.0005
491 ASCITES 15 0.0005
492 BICYTOPENIA 1 0.0005
493 ANAEMIA 96 0.0005
494 OESOPHAGEAL CANDIDIASIS 2 0.0005
495 PROTHROMBIN TIME PROLONGED 3 0.0005
496 GOUT 9 0.0005
497 POLYNEUROPATHY 6 0.0005
498 SKIN PAPILLOMA 2 0.0005
499 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
500 LEUKOCYTOSIS 9 0.0005
501 CARDIAC ARREST 41 0.0005
502 DIALYSIS 7 0.0005
503 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
504 EXTRAVASATION 2 0.0005
505 ESCHERICHIA INFECTION 4 0.0005
506 ANAPHYLACTOID REACTION 2 0.0005
507 VENTRICULAR TACHYCARDIA 8 0.0005
508 ACUTE CORONARY SYNDROME 4 0.0005
509 ILEUS 6 0.0005
510 CYTOMEGALOVIRUS INFECTION 8 0.0005
511 GASTROINTESTINAL PERFORATION 2 0.0005
512 SHOCK 11 0.0005
513 FOLLICULITIS 5 0.0005
514 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
515 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
516 ENTERITIS 3 0.0005
517 OCCUPATIONAL EXPOSURE TO PRODUCT 3 0.0005
518 UNRESPONSIVE TO STIMULI 12 0.0005
519 DISEASE PROGRESSION 55 0.0005
520 DELIRIUM 16 0.0005
521 PULMONARY CONGESTION 6 0.0005
522 PARONYCHIA 2 0.0005
523 DEVICE RELATED INFECTION 7 0.0005
524 CLOSTRIDIUM TEST POSITIVE 1 0.0005
525 LUNG INFECTION 7 0.0005
526 CARDIAC FAILURE ACUTE 3 0.0004
527 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
528 HYPOTENSION 90 0.0004
529 BACTERIAL TEST POSITIVE 1 0.0004
530 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
531 CALCINOSIS 1 0.0004
532 BRONCHIECTASIS 3 0.0004
533 ULCER 7 0.0004
534 HAEMATEMESIS 11 0.0004
535 APHTHOUS STOMATITIS 1 0.0004
536 CHRONIC MYELOID LEUKAEMIA 2 0.0004
537 LOCALISED OEDEMA 2 0.0004
538 OXYGEN SATURATION DECREASED 24 0.0004
539 PYREXIA 147 0.0004
540 CARDIAC TAMPONADE 2 0.0004
541 HYPERLIPIDAEMIA 5 0.0004
542 DERMATITIS BULLOUS 3 0.0004
543 MOUTH HAEMORRHAGE 3 0.0004
544 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
545 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
546 BREATH SOUNDS ABNORMAL 2 0.0004
547 STAPHYLOCOCCAL SEPSIS 2 0.0004
548 HOSPICE CARE 4 0.0004
549 STEVENS-JOHNSON SYNDROME 9 0.0004
550 PNEUMONITIS 11 0.0004
551 INFLAMMATORY MARKER INCREASED 2 0.0004
552 PLATELET COUNT DECREASED 43 0.0004
553 ABDOMINAL TENDERNESS 2 0.0004
554 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
555 PNEUMONIA ASPIRATION 10 0.0004
556 BRAIN OEDEMA 5 0.0004
557 RENAL IMPAIRMENT 33 0.0004
558 SUBARACHNOID HAEMORRHAGE 4 0.0004
559 AORTIC ARTERIOSCLEROSIS 1 0.0004
560 CARDIAC FAILURE 31 0.0004
561 ACTINIC KERATOSIS 1 0.0004
562 VENTRICULAR EXTRASYSTOLES 4 0.0004
563 COMPARTMENT SYNDROME 1 0.0004
564 DRUG-INDUCED LIVER INJURY 12 0.0004
565 ARRHYTHMIA 18 0.0004
566 AGRANULOCYTOSIS 7 0.0004
567 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
568 ATRIAL FLUTTER 3 0.0004
569 ANAL FISTULA 2 0.0004
570 AREFLEXIA 1 0.0004
571 LIVER FUNCTION TEST INCREASED 8 0.0004
572 RHINITIS 3 0.0004
573 JAUNDICE 10 0.0004
574 SHOCK HAEMORRHAGIC 3 0.0004
575 DECUBITUS ULCER 3 0.0004
576 SKIN LACERATION 4 0.0004
577 CLUMSINESS 1 0.0004
578 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
579 INTESTINAL ISCHAEMIA 2 0.0004
580 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
581 EMBOLISM 3 0.0004
582 GASTRIC ULCER HAEMORRHAGE 2 0.0004
583 MENTAL STATUS CHANGES 10 0.0004
584 ANGIOPATHY 2 0.0004
585 REBOUND EFFECT 4 0.0004
586 CEREBRAL THROMBOSIS 1 0.0004
587 HAEMATOCRIT DECREASED 7 0.0004
588 PERONEAL NERVE PALSY 2 0.0004
589 NEUTROPHILIA 2 0.0004
590 HAEMATURIA 12 0.0004
591 HEPATIC FUNCTION ABNORMAL 13 0.0003
592 BLOOD MAGNESIUM DECREASED 3 0.0003
593 FULL BLOOD COUNT DECREASED 7 0.0003
594 MYOPATHY 3 0.0003
595 NEOPLASM PROGRESSION 12 0.0003
596 URINE OUTPUT DECREASED 3 0.0003
597 BLOOD CALCIUM INCREASED 3 0.0003
598 CARDIOMYOPATHY 5 0.0003
599 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
600 CREPITATIONS 1 0.0003
601 BLOOD CULTURE POSITIVE 1 0.0003
602 MYELOSUPPRESSION 12 0.0003
603 CENTRAL VENOUS CATHETERISATION 1 0.0003
604 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
605 FUNGAL INFECTION 11 0.0003
606 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
607 NEURALGIA 8 0.0003
608 RETCHING 7 0.0003
609 CHEST X-RAY ABNORMAL 1 0.0003
610 SMALL INTESTINAL OBSTRUCTION 4 0.0003
611 HAEMOPTYSIS 9 0.0003
612 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
613 BLOOD BLISTER 1 0.0003
614 BLOOD CREATININE DECREASED 1 0.0003
615 ATRIAL FIBRILLATION 31 0.0003
616 COLITIS 12 0.0003
617 RASH MACULO-PAPULAR 7 0.0003
618 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
619 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
620 PULMONARY OEDEMA 14 0.0003
621 LYMPHADENOPATHY 11 0.0003
622 HYPERCHOLESTEROLAEMIA 3 0.0003
623 CORONAVIRUS INFECTION 2 0.0003
624 RESPIRATORY DISORDER 9 0.0003
625 HYPOTONIA 3 0.0003
626 TERMINAL STATE 2 0.0003
627 CLOSTRIDIAL INFECTION 1 0.0003
628 OEDEMA 16 0.0003
629 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
630 BODY TEMPERATURE INCREASED 6 0.0003
631 TACHYCARDIA 26 0.0003
632 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
633 BRONCHOPNEUMONIA 1 0.0003
634 PERIPHERAL COLDNESS 4 0.0003
635 APLASIA PURE RED CELL 1 0.0003
636 RESPIRATORY ARREST 8 0.0003
637 CERVICAL VERTEBRAL FRACTURE 1 0.0003
638 BLOOD CREATININE ABNORMAL 1 0.0003
639 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
640 PARALYSIS 4 0.0003
641 LACTIC ACIDOSIS 9 0.0003
642 CELLULITIS 14 0.0003
643 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
644 MYELODYSPLASTIC SYNDROME 4 0.0003
645 INFECTION 40 0.0003
646 LIVER FUNCTION TEST ABNORMAL 8 0.0003
647 MELAENA 6 0.0003
648 HYPERTENSIVE CRISIS 3 0.0003
649 PULMONARY MASS 4 0.0003
650 HAEMORRHAGE INTRACRANIAL 4 0.0003
651 NEPHROPATHY TOXIC 3 0.0003
652 HYDRONEPHROSIS 2 0.0003
653 MITRAL VALVE INCOMPETENCE 3 0.0003
654 CHEMOTHERAPY 1 0.0003
655 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
656 NEPHROLITHIASIS 12 0.0003
657 CLAVICLE FRACTURE 1 0.0003
658 LIPASE INCREASED 2 0.0003
659 NEOPLASM 3 0.0003
660 LYMPHOMA 4 0.0003
661 APHTHOUS ULCER 2 0.0003
662 EJECTION FRACTION DECREASED 4 0.0003
663 APNOEA 2 0.0003
664 HEART RATE DECREASED 9 0.0003
665 BONE PAIN 15 0.0003
666 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
667 PNEUMONIA 82 0.0003
668 CYSTITIS 8 0.0003
669 CEREBRAL ATROPHY 1 0.0003
670 PRESCRIBED UNDERDOSE 5 0.0003
671 ARTERIOSPASM CORONARY 1 0.0002
672 MUSCLE DISORDER 2 0.0002
673 OFF LABEL USE 216 0.0002
674 ANGINA PECTORIS 7 0.0002
675 SECOND PRIMARY MALIGNANCY 2 0.0002
676 HEMIPLEGIA 2 0.0002
677 RASH PRURITIC 13 0.0002
678 DERMATITIS ALLERGIC 3 0.0002
679 MOUTH ULCERATION 5 0.0002
680 FACE OEDEMA 4 0.0002
681 FLUID RETENTION 12 0.0002
682 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
683 LACRIMATION INCREASED 7 0.0002
684 HYSTERECTOMY 2 0.0002
685 RESPIRATORY TRACT INFECTION 6 0.0002
686 RASH ERYTHEMATOUS 11 0.0002
687 ABDOMINAL DISTENSION 24 0.0002
688 NODULE 3 0.0002
689 OEDEMA PERIPHERAL 28 0.0002
690 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
691 BLOOD CREATINE INCREASED 1 0.0002
692 CONFUSIONAL STATE 36 0.0002
693 THERAPY NON-RESPONDER 10 0.0002
694 HYPERGLYCAEMIA 8 0.0002
695 ACUTE HEPATIC FAILURE 3 0.0002
696 END STAGE RENAL DISEASE 4 0.0002
697 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
698 PNEUMONIA BACTERIAL 2 0.0002
699 BRAIN NEOPLASM 2 0.0002
700 PERICARDIAL EFFUSION 5 0.0002
701 CONJUNCTIVITIS 4 0.0002
702 HEPATIC ENCEPHALOPATHY 2 0.0002
703 CHILLS 25 0.0002
704 HEPATIC CIRRHOSIS 4 0.0002
705 DYSARTHRIA 8 0.0002
706 SQUAMOUS CELL CARCINOMA 2 0.0002
707 LEUKAEMIA 2 0.0002
708 SPUTUM DISCOLOURED 2 0.0002
709 PRODUCT PACKAGING ISSUE 2 0.0002
710 VIRAL INFECTION 7 0.0002
711 BRONCHOSPASM 3 0.0002
712 RED BLOOD CELL COUNT DECREASED 6 0.0002
713 BRADYCARDIA 11 0.0002
714 AUTOIMMUNE DISORDER 2 0.0002
715 HAEMOGLOBIN DECREASED 21 0.0002
716 DISORIENTATION 8 0.0002
717 CONDITION AGGRAVATED 61 0.0002
718 CORONARY ARTERY DISEASE 6 0.0002
719 AMMONIA INCREASED 1 0.0002
720 CACHEXIA 1 0.0002
721 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
722 ANKLE FRACTURE 3 0.0002
723 RENAL DISORDER 9 0.0002
724 PERITONITIS 4 0.0002
725 PULMONARY HYPERTENSION 4 0.0002
726 APLASTIC ANAEMIA 1 0.0002
727 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
728 TRANSFUSION 2 0.0002
729 CYANOSIS 3 0.0002
730 FULL BLOOD COUNT ABNORMAL 2 0.0002
731 COMPRESSION FRACTURE 1 0.0002
732 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
733 ANAL ABSCESS 1 0.0002
734 MULTIPLE FRACTURES 3 0.0002
735 STOMATITIS 11 0.0002
736 ANAPHYLACTIC REACTION 10 0.0002
737 MEDICATION ERROR 10 0.0002
738 PULMONARY EMBOLISM 17 0.0002
739 MALNUTRITION 2 0.0002
740 INTESTINAL PERFORATION 2 0.0002
741 BLISTER 10 0.0002
742 HEMIPARESIS 3 0.0002
743 STATUS EPILEPTICUS 2 0.0002
744 CHOLECYSTITIS ACUTE 1 0.0002
745 MICTURITION URGENCY 2 0.0002
746 EPISTAXIS 13 0.0002
747 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
748 DEHYDRATION 23 0.0002
749 EYELID OEDEMA 2 0.0002
750 PANCREATITIS 9 0.0002
751 ACUTE MYOCARDIAL INFARCTION 5 0.0002
752 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
753 ISCHAEMIC STROKE 3 0.0002
754 CARDIAC PACEMAKER INSERTION 1 0.0002
755 SYNOVITIS 3 0.0002
756 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
757 NO THERAPEUTIC RESPONSE 2 0.0002
758 LIVER INJURY 4 0.0002
759 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
760 CHOLANGITIS 1 0.0002
761 CYST 2 0.0002
762 HEPATIC STEATOSIS 3 0.0002
763 CONSTIPATION 35 0.0002
764 FLATULENCE 9 0.0002
765 BLOOD URINE PRESENT 3 0.0002
766 GASTRIC ULCER 3 0.0002
767 CARDIOVASCULAR DISORDER 4 0.0002
768 HEPATIC CYTOLYSIS 2 0.0002
769 INTRAOCULAR PRESSURE INCREASED 2 0.0002
770 HEPATITIS 4 0.0002
771 VOMITING 72 0.0002
772 DEAFNESS 4 0.0002
773 TOOTH INFECTION 2 0.0002
774 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
775 SOMNOLENCE 30 0.0001
776 PRODUCT STORAGE ERROR 13 0.0001
777 CEREBROVASCULAR ACCIDENT 25 0.0001
778 NEUROPATHY PERIPHERAL 14 0.0001
779 DRUG TOXICITY 2 0.0001
780 ABNORMAL LOSS OF WEIGHT 1 0.0001
781 SKIN LESION 4 0.0001
782 SKIN REACTION 2 0.0001
783 PRODUCT DISPENSING ERROR 3 0.0001
784 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
785 BLINDNESS TRANSIENT 1 0.0001
786 CEREBRAL DISORDER 1 0.0001
787 SKIN HAEMORRHAGE 2 0.0001
788 DYSPNOEA 76 0.0001
789 ORAL PAIN 3 0.0001
790 HEPATIC ENZYME INCREASED 9 0.0001
791 SKIN DISCOLOURATION 6 0.0001
792 SKIN EXFOLIATION 11 0.0001
793 CHEST PAIN 24 0.0001
794 BLOOD CHOLESTEROL INCREASED 6 0.0001
795 THERAPY PARTIAL RESPONDER 2 0.0001
796 HYPERTENSION 27 0.0001
797 DISEASE RECURRENCE 6 0.0001
798 THROMBOSIS 10 0.0001
799 HYPOGLYCAEMIA 6 0.0001
800 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
801 ASPHYXIA 1 0.0001
802 LUNG DISORDER 6 0.0001
803 TREMOR 20 0.0001
804 URINARY RETENTION 4 0.0001
805 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
806 HYPOPHAGIA 3 0.0001
807 PRODUCT USE ISSUE 22 0.0001
808 INFLUENZA 13 0.0001
809 HAEMATOMA 3 0.0001
810 MENTAL DISORDER 5 0.0001
811 SEDATION 3 0.0001
812 COLD SWEAT 2 0.0001
813 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
814 LIVER DISORDER 5 0.0001
815 CARDIOTOXICITY 1 0.0001
816 ANAL INCONTINENCE 1 0.0001
817 COVID-19 19 0.0001
818 FLUSHING 11 0.0001
819 DECREASED APPETITE 25 0.0001
820 ABDOMINAL PAIN 25 0.0001
821 DEMENTIA 3 0.0001
822 DRUG INEFFECTIVE 140 0.0001
823 ABORTION INDUCED 1 0.0001
824 DYSPNOEA EXERTIONAL 4 0.0001
825 DYSPHAGIA 10 0.0001
826 HAEMORRHAGE 11 0.0001
827 PROTEINURIA 2 0.0001
828 MUSCULOSKELETAL DISORDER 2 0.0001
829 DIABETES MELLITUS 8 0.0001
830 HERPES ZOSTER 6 0.0001
831 PULMONARY FIBROSIS 2 0.0001
832 WHEEZING 6 0.0001
833 ASTHENIA 38 0.0001
834 ABNORMAL BEHAVIOUR 4 0.0001
835 BLOOD POTASSIUM DECREASED 3 0.0001
836 CHEST DISCOMFORT 10 0.0001
837 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
838 AGITATION 7 0.0001
839 BRONCHITIS 7 0.0001
840 DIARRHOEA 61 0.0001
841 JOINT INJURY 2 0.0001
842 SKIN CANCER 2 0.0001
843 COUGH 26 0.0001
844 BALANCE DISORDER 8 0.0001
845 DEEP VEIN THROMBOSIS 6 0.0001
846 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
847 FAECES DISCOLOURED 2 0.0001
848 NAUSEA 73 0.0001
849 INTENTIONAL PRODUCT MISUSE 8 0.0001
850 IMPAIRED HEALING 3 0.0001
851 DEATH 78 0.0001
852 SYNCOPE 9 0.0001
853 GASTROINTESTINAL DISORDER 8 0.0001
854 PANCREATITIS ACUTE 2 0.0001
855 HEART RATE IRREGULAR 2 0.0001
856 URINARY TRACT INFECTION 15 0.0001
857 CONVULSION 5 0.0001
858 LETHARGY 5 0.0001
859 MUSCLE TWITCHING 2 0.0001
860 DRY MOUTH 7 0.0001
861 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
862 SWELLING 8 0.0001
863 ATAXIA 1 0.0001
864 CHOLECYSTITIS 1 0.0001
865 MENTAL IMPAIRMENT 2 0.0001
866 CEREBRAL INFARCTION 2 0.0001
867 MUSCULAR WEAKNESS 9 0.0001
868 SEIZURE 9 0.0001
869 ANAPHYLACTIC SHOCK 2 0.0001
870 INFLAMMATION 4 0.0001
871 SKIN ULCER 2 0.0001
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
873 LIMB INJURY 2 0.0001
874 PALLOR 2 0.0001
875 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
876 DRUG INTOLERANCE 7 0.0001
877 TREATMENT FAILURE 6 0.0001
878 CARPAL TUNNEL SYNDROME 1 0.0001
879 BLINDNESS UNILATERAL 1 0.0001
880 LOSS OF CONSCIOUSNESS 9 0.0001
881 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
882 INCORRECT DOSE ADMINISTERED 16 0.0001
883 SKIN BURNING SENSATION 5 0.0001
884 DRUG INTERACTION 11 0.0001
885 DYSSTASIA 2 0.0001
886 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
887 LABORATORY TEST ABNORMAL 2 0.0001
888 URINARY INCONTINENCE 2 0.0001
889 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
890 CHRONIC KIDNEY DISEASE 5 0.0001
891 BLOOD PRESSURE INCREASED 10 0.0001
892 DRUG ADMINISTRATION ERROR 2 0.0001
893 HYPERSENSITIVITY 12 0.0001
894 PRODUCTIVE COUGH 3 0.0001
895 ABSCESS 1 0.0001
896 HYPERHIDROSIS 8 0.0001
897 NIGHT SWEATS 2 0.0001
898 RASH 27 0.0001
899 RHINORRHOEA 4 0.0001
900 EYE DISORDER 2 0.0001
901 BACK PAIN 14 0.0001
902 BLOOD PRESSURE DECREASED 4 0.0001
903 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
904 FATIGUE 45 0.0001
905 MALAISE 25 0.0001
906 SLEEP DISORDER 4 0.0001
907 CEREBRAL HAEMORRHAGE 2 0.0001
908 DYSURIA 2 0.0001
909 BLOOD GLUCOSE ABNORMAL 1 0.0001
910 ERYTHEMA 11 0.0001
911 CARDIAC DISORDER 5 0.0001
912 INTESTINAL OBSTRUCTION 2 0.0001
913 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
914 PARAESTHESIA 8 0.0001
915 CATARACT 3 0.0001
916 BLOOD PRESSURE ABNORMAL 1 0.0001
917 WEIGHT DECREASED 14 0.0001
918 DIZZINESS 25 0.0001
919 CARDIAC FAILURE CONGESTIVE 4 0.0000
920 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
921 VERTIGO 3 0.0000
922 DYSKINESIA 2 0.0000
923 DISCOMFORT 3 0.0000
924 ABDOMINAL PAIN UPPER 10 0.0000
925 EXPOSURE DURING PREGNANCY 3 0.0000
926 FALL 16 0.0000
927 TOXICITY TO VARIOUS AGENTS 8 0.0000
928 PRODUCT DOSE OMISSION 3 0.0000
929 MYOCARDIAL INFARCTION 8 0.0000
930 ANGIOEDEMA 2 0.0000
931 DRY SKIN 6 0.0000
932 PRURITUS 17 0.0000
933 ARTHRALGIA 18 0.0000
934 COGNITIVE DISORDER 2 0.0000
935 BURNING SENSATION 3 0.0000
936 OCULAR HYPERAEMIA 2 0.0000
937 CONTUSION 4 0.0000
938 INTERSTITIAL LUNG DISEASE 2 0.0000
939 UNDERDOSE 3 0.0000
940 HEART RATE INCREASED 4 0.0000
941 DRY EYE 2 0.0000
942 AGGRESSION 2 0.0000
943 HEADACHE 25 0.0000
944 UNEVALUABLE EVENT 3 0.0000
945 ILLNESS 4 0.0000
946 ARTHRITIS 3 0.0000
947 HAEMATOCHEZIA 2 0.0000
948 PAIN 22 0.0000
949 NECK PAIN 2 0.0000
950 WEIGHT INCREASED 8 0.0000
951 EYE PAIN 2 0.0000
952 NASAL CONGESTION 2 0.0000
953 ADVERSE DRUG REACTION 3 0.0000
954 ILL-DEFINED DISORDER 2 0.0000
955 HOSPITALISATION 5 0.0000
956 PERIPHERAL SWELLING 5 0.0000
957 OROPHARYNGEAL PAIN 3 0.0000
958 VISUAL IMPAIRMENT 4 0.0000
959 ANXIETY 9 0.0000
960 PAIN IN EXTREMITY 9 0.0000
961 CHOLELITHIASIS 1 0.0000
962 DYSPEPSIA 3 0.0000
963 VISION BLURRED 4 0.0000
964 MEMORY IMPAIRMENT 4 0.0000
965 INJURY 2 0.0000
966 ASTHMA 3 0.0000
967 HOT FLUSH 2 0.0000
968 BLINDNESS 1 0.0000
969 URTICARIA 4 0.0000
970 ABDOMINAL DISCOMFORT 4 0.0000
971 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
972 MUSCULOSKELETAL STIFFNESS 2 0.0000
973 NO ADVERSE EVENT 4 0.0000
974 ADVERSE EVENT 2 0.0000
975 COMA 1 0.0000
976 MIGRAINE 2 0.0000
977 COLORECTAL CANCER 1 0.0000
978 BLOOD GLUCOSE DECREASED 1 0.0000
979 INSOMNIA 5 0.0000
980 ARTHROPATHY 1 0.0000
981 MYALGIA 3 0.0000
982 PRODUCT DOSE OMISSION ISSUE 5 0.0000
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
984 JOINT SWELLING 2 0.0000
985 MUSCLE SPASMS 3 0.0000
986 AMNESIA 1 0.0000
987 ALOPECIA 3 0.0000
988 PRODUCT QUALITY ISSUE 2 0.0000
989 OVERDOSE 2 0.0000
990 DEPRESSION 2 0.0000
991 FEELING ABNORMAL 2 0.0000
992 BLOOD GLUCOSE INCREASED 1 0.0000